These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1152 related items for PubMed ID: 17092454

  • 1. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
    Gregersen N, Jensen PT, Giraldi AE.
    Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
    [Abstract] [Full Text] [Related]

  • 2. [Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects].
    Gregersen N, Hilmand CB, Jensen PT, Giraldi AG.
    Ugeskr Laeger; 2006 Feb 06; 168(6):559-63. PubMed ID: 16476214
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S, Moghasemi M, Faghihzadeh S.
    Climacteric; 2010 Apr 06; 13(2):147-56. PubMed ID: 19731119
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic options for postmenopausal female sexual dysfunction.
    Al-Azzawi F, Bitzer J, Brandenburg U, Castelo-Branco C, Graziottin A, Kenemans P, Lachowsky M, Mimoun S, Nappi RE, Palacios S, Schwenkhagen A, Studd J, Wylie K, Zahradnik HP.
    Climacteric; 2010 Apr 06; 13(2):103-20. PubMed ID: 19958161
    [Abstract] [Full Text] [Related]

  • 5. Testosterone therapy in women: a review.
    Bolour S, Braunstein G.
    Int J Impot Res; 2005 Apr 06; 17(5):399-408. PubMed ID: 15889125
    [Abstract] [Full Text] [Related]

  • 6. Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.
    Osmanağaoğlu MA, Atasaral T, Baltaci D, Bozkaya H.
    Climacteric; 2006 Dec 06; 9(6):464-72. PubMed ID: 17085380
    [Abstract] [Full Text] [Related]

  • 7. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial.
    Basson R, Brotto LA.
    BJOG; 2003 Nov 06; 110(11):1014-24. PubMed ID: 14592587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause.
    Nappi RE, Lello S, Melis GB, Albani F, Polatti F, Genazzani AR.
    Climacteric; 2009 Dec 06; 12(6):533-40. PubMed ID: 19905905
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Menopause and sexuality: prevalence of symptoms and impact on quality of life.
    Nappi RE, Lachowsky M.
    Maturitas; 2009 Jun 20; 63(2):138-41. PubMed ID: 19464129
    [Abstract] [Full Text] [Related]

  • 13. Advances in pharmacotherapy for treating female sexual dysfunction.
    Nappi RE, Cucinella L.
    Expert Opin Pharmacother; 2015 Apr 20; 16(6):875-87. PubMed ID: 25732267
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
    Wu MH, Pan HA, Wang ST, Hsu CC, Chang FM, Huang KE.
    Climacteric; 2001 Dec 20; 4(4):314-9. PubMed ID: 11770188
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sexuality and the menopause.
    Pitkin J.
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb 20; 23(1):33-52. PubMed ID: 19058763
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.